Optical coherence tomography (OCT) permits the visualization and segmentation of Bruch\'s membrane, Bruch\'s membrane opening (BMO), the anterior scleral surface, the neural canal boundary, and the anterior scleral canal opening (ASCO; [Figs. 1](#i1552-5783-60-2-795-f01){ref-type="fig"}, [2](#i1552-5783-60-2-795-f02){ref-type="fig"}).[@i1552-5783-60-2-795-b01] Using these OCT landmarks to measure peripapillary choroidal thickness (PCT) enables both its cross-sectional characterization in healthy and diseased eyes and the longitudinal detection of PCT change in the locations that give rise to peripapillary atrophy ([Fig. 3](#i1552-5783-60-2-795-f03){ref-type="fig"}). The contribution of PCT and its change over time to the detection of glaucoma and other progressive conditions such as degenerative myopia can thus be assessed.

![Manual segmentation of each radial B-scan. (A) A representative 15^0^ radial B-scan is shown with its location depicted in green within the inlayed infrared reflectance (IR) image (bottom left). (B) Manually segmented ONH landmarks for this study within the B-scan shown in (A). Orange lines/points are the posterior surface of the Bruch\'s Membrane/RPE complex, gold lines/points are the anterior surface of the sclera. Green lines/points are the neural canal wall, red points are BMO, and blue points are the ASCO. (C) Point cloud of segmented points from the complete set of 24 radial B-scans obtained for this ONH.](i1552-5783-60-2-795-f01){#i1552-5783-60-2-795-f01}

![Measurement of peripapillary choroidal thickness at six distances (measured in microns) from the ASCO within the ASCO reference plane. Within the three-dimensional point cloud of segmented points from each OCT ONH data set ([Figure 1](#i1552-5783-60-2-795-f01){ref-type="fig"}C, above), Bruch\'s membrane and anterior scleral surface points were interpolated using b-splines. PCT was assessed in microns at six distances (vertical blue dotted lines) from the ASCO, measured within the ASCO reference plane (horizontal blue line). Each measurement distance was projected from the ASCO to the anterior sclera surface (yellow dots). At each anterior scleral measurement point, PCT was defined by the minimum distance to the posterior surface of Bruch\'s membrane (green arrows: PCT-100, PCT-300, PCT-500, PCT-700, PCT-900, and PCT-1100, respectively). In this study, PCT measurements within the regions of border tissues of Elschnig (BTE) obliqueness (pink externally oblique, left; blue internally oblique, right) were not included in the normative values as explained in [Figure 3](#i1552-5783-60-2-795-f03){ref-type="fig"}.](i1552-5783-60-2-795-f02){#i1552-5783-60-2-795-f02}

![Although regions of internally and externally oblique BTE are defined by the offset of OCT BMO relative to OCT ASCO, PCT measurements within these regions are not included in the normative values of this report. (A) Color optic disc photo of the study eye of subject FDA287, with colocalized OCT ASCO (blue) and OCT BMO (red) points. The location and orientation (B1--B2) and (D1-D2) of the cropped B-scans shown in B, C and D, E are shown. (B) Cropped superior-nasal B-scan in a region of internally oblique BTE, (B1-B2) shown in A and delineated in (C). Note that BMO is "internal" to ASCO (or closer to the center of the disc). Note also that the suggestion of a juxta-scleral canal posterior ciliary vessel entering the choroid from the sclera (red dots). (D) Cropped inferior-temporal B-scan in a region of externally oblique BTE (D1-D2) shown in A and delineated in (E). Note that BMO is "external" to ASCO (or farther from the center of the disc). Although externally oblique border tissues do not represent atrophy in any form, they are commonly referred to as gamma peripapillary atrophy in the clinical[@i1552-5783-60-2-795-b55] and OCT[@i1552-5783-60-2-795-b04],[@i1552-5783-60-2-795-b56],[@i1552-5783-60-2-795-b57] literature. (F) The clinical extent of internally (blue) and externally (pink) oblique BTE in a healthy study eye with mild myopia (spherical equivalent −4.25D, axial length 25.13 mm). In this cross-sectional study, PCT measurements within the regions of BTE obliqueness were not included in the normative values because when present the density of the border tissues themselves and the adjacent choroidal septa made the presence of active choroidal vasculature difficult to determine and because the occurrence and regional distribution of internally and externally oblique border tissues are not consistent among all human eyes.[@i1552-5783-60-2-795-b20] However, PCT can be measured relative to the ASCO within both forms of oblique border tissue regions, and the individual eye longitudinal change within these regions may be clinically important.](i1552-5783-60-2-795-f03){#i1552-5783-60-2-795-f03}

Alteration to the tissues of the peripapillary sclera, posterior ciliary arteries, choroid, and retina are thought to underlie the various clinical presentations of peripapillary atrophy in aging, glaucoma, and myopia.[@i1552-5783-60-2-795-b02][@i1552-5783-60-2-795-b03][@i1552-5783-60-2-795-b04][@i1552-5783-60-2-795-b05][@i1552-5783-60-2-795-b06][@i1552-5783-60-2-795-b07]--[@i1552-5783-60-2-795-b08] Hayreh[@i1552-5783-60-2-795-b09] and others[@i1552-5783-60-2-795-b10],[@i1552-5783-60-2-795-b11] have hypothesized that peripapillary atrophy in glaucoma is a manifestation of compromised peripapillary choroidal blood flow within the posterior ciliary artery branches that penetrated the sclera immediately adjacent to the ASCO (hereafter referred to as the juxta-scleral canal posterior ciliary artery branches; [Fig. 3](#i1552-5783-60-2-795-f03){ref-type="fig"}).[@i1552-5783-60-2-795-b09],[@i1552-5783-60-2-795-b12] These branches are important because they also supply the circle of Zinn-Haller,[@i1552-5783-60-2-795-b09],[@i1552-5783-60-2-795-b13],[@i1552-5783-60-2-795-b14] the laminar beam capillaries, and the retrolaminar orbital optic nerve and may thus separately contribute to the optic nerve head (ONH) pathophysiology of aging, glaucoma, and myopia.[@i1552-5783-60-2-795-b02],[@i1552-5783-60-2-795-b12]

As a first step toward using OCT measurements of PCT in the detection of glaucoma or pathological myopia and their progression, the purpose of the present study was to measure PCT in a large group of healthy eyes relative to the ASCO at six proximal to distal measurement locations (100 μm, 300 μm, 500 μm, 700 μm, 900 μm, and 1100 μm, respectively). A second purpose of this study was to report and compare the influence of age, axial length, ethnicity, sex, IOP, and ASCO area on peripapillary choroidal thickness at each measurement location both globally and by foveal-BMO (FoBMO) 30^0^ sectors.[@i1552-5783-60-2-795-b01]

The majority of studies in which PCT is measured by OCT employ BMO as the reference opening for its regional quantification and Bruch\'s membrane as the reference for the thickness measurement.[@i1552-5783-60-2-795-b15][@i1552-5783-60-2-795-b16]--[@i1552-5783-60-2-795-b17] PCT is measured from Bruch\'s membrane to the anterior scleral surface at measurement points that are located at fixed distances along Bruch\'s membrane from BMO. In this study, PCT was assessed at six distances from the ASCO, measured within an ASCO reference plane. Each measurement location was projected to the anterior sclera surface from which a measurement to Bruch\'s membrane was made ([Fig. 2](#i1552-5783-60-2-795-f02){ref-type="fig"}). We chose this approach for four reasons. First, BMO can be difficult to distinguish within the temporal region of myopic eyes.[@i1552-5783-60-2-795-b18] Second, segmenting both the ASCO and BMO in a given eye primarily identifies the location and extent of oblique border tissue regions ([Fig. 3](#i1552-5783-60-2-795-f03){ref-type="fig"}). Third, we believe that the ASCO and the anterior scleral surface will be more stable as anatomic landmarks than BMO and Bruch\'s membrane[@i1552-5783-60-2-795-b01],[@i1552-5783-60-2-795-b16] during the course of peripapillary choroidal thinning in aging, glaucoma, and myopia. Fourth, measurement locations within an ASCO reference plane should be less influenced by disease-related distortions in the ASCO or anterior scleral canal surface.[@i1552-5783-60-2-795-b01],[@i1552-5783-60-2-795-b16],[@i1552-5783-60-2-795-b19]

In the present cross-sectional study, we do not include PCT measurements within oblique border tissue regions because the density of the border tissues themselves and the adjacent choroidal septa make the presence of active choroidal vasculature difficult to determine ([Fig. 3](#i1552-5783-60-2-795-f03){ref-type="fig"}) and because the regional distribution and extent of internally and externally oblique border tissues are not consistent among human eyes.[@i1552-5783-60-2-795-b20] However, we predict that oblique border tissue regions will be most susceptible to longitudinal PCT thinning because PCT is the thinnest in these regions ([Fig. 3](#i1552-5783-60-2-795-f03){ref-type="fig"}). We further predict that longitudinal thinning within the border tissue regions will precede the onset and progression of peripapillary microvascular drop out[@i1552-5783-60-2-795-b11],[@i1552-5783-60-2-795-b21],[@i1552-5783-60-2-795-b22] and atrophy[@i1552-5783-60-2-795-b11],[@i1552-5783-60-2-795-b23] in the aging, glaucomatous, and myopic eye. Our proposed method can enable longitudinal PCT measurements to be made in the internally and externally oblique border tissue regions of at-risk eyes, thereby allowing the clinical timing of longitudinal OCT PCT thinning and OCT angiographic[@i1552-5783-60-2-795-b11],[@i1552-5783-60-2-795-b21],[@i1552-5783-60-2-795-b22] change to be assessed.

Methods {#s2}
=======

Conventions {#s2a}
-----------

A detailed description of our study participants and our methods of data acquisition has been previously published.[@i1552-5783-60-2-795-b01] We use the term *ONH* to refer to the tissues that are contained within the scleral canal and those immediately adjacent to it (i.e., the peripapillary sclera, choroid, and retina as well as the retrolaminar optic nerve). PCT is the distance between the anterior scleral surface and Bruch\'s membrane and is always a positive number or zero. Factors that have positive and negative effects on PCT correlate to thicker and thinner PCT, respectively. Global PCT refers to PCT without regard to sector.

Participants {#s2b}
------------

A total of 362 healthy individuals participated in this study[@i1552-5783-60-2-795-b01]: 246 self-identified European descent,[@i1552-5783-60-2-795-b24] 47 Hispanic ethnicity, 47 African descent, 19 Asian descent, and 3 Native American descent participants. The participants were recruited to represent the ethnic composition of the U.S. population[@i1552-5783-60-2-795-b25] as mandated by the U.S. Food and Drug Administration. Consent documents approved by the institutional review board were signed by each participant. The study adhered to the Declaration of Helsinki for research involving human participants.

At the first visit, medical and ophthalmic histories were obtained, followed by anterior segment and external eye examinations, Van Herrick angle assessment, crystalline lens evaluation, standard Snellen or Early Treatment Diabetic Retinopathy Study visual acuity, refraction, central keratometry, and axial length assessments. Standard automated perimetry (Humphrey Field Analyzer \[Carl Zeiss Meditec, Dublin, CA, USA\], 24--2 Swedish Interactive Thresholding Algorithm), was repeated once if deemed unreliable or outside normal limits (see below). OCT examination, ophthalmoscopic examination of the posterior pole, and stereophotography were followed by Goldmann tonometry and pachymetry.

Inclusion criteria included age 18 to 90 years old; no history of glaucoma, IOP ≤ 21 mm Hg; best corrected visual acuity ≥ 20/40, refraction less than ±6.00 diopter (D) sphere and ±2.00 D cylinder; (4) Glaucoma Hemifield Test and mean deviation within normal limits. Exclusion criteria included unusable stereo photographs or insufficient OCT image quality (quality score \< 20); clinically abnormal optic disc appearance; any intraocular surgery (except uncomplicated cataract surgery) or vitreous, retinal, choroidal, or neurophthalmological disease; and ethnic group other than those listed. All test procedures were performed on both eyes of each participant, but only one eye was randomized for analysis.

OCT Image Acquisition and Segmentation {#s2c}
--------------------------------------

The ONH, peripapillary retinal nerve fiber layer (RNFL) and macula were imaged with spectral domain OCT (Spectralis, Heidelberg Engineering GmbH, Heidelberg, Germany; software version Heyex 1.9.10.0). For each eye, prior to image acquisition, refractive correction and keratometry values were entered into the instrument data base and the operator manually defined the fovea with a live B-scan, then centered the imaging field on the ONH, where the two BMO points in each of two perpendicular ONH radial B-scans were identified. These steps established the eye-specific, FoBMO axis that was used as the reference for the acquisition of all scans.[@i1552-5783-60-2-795-b26] The complete ONH imaging pattern consisted of 24 radially equidistant, 15° B-scans (768 A-lines each) centered on the BMO and acquired in enhanced depth imaging[@i1552-5783-60-2-795-b27] mode, with an average of 25 repetitions each.

Our strategy for OCT ONH image manual segmentation has been described previously ([Fig. 1](#i1552-5783-60-2-795-f01){ref-type="fig"}).[@i1552-5783-60-2-795-b01] Raw OCT volumes along with automatic segmented BMO points were exported from the device and imported into our custom three-dimensional visualization and segmentation software (ATL 3D Suite).[@i1552-5783-60-2-795-b28] ONH and peripapillary landmarks were manually segmented in each radial B-scan (24 total) of each OCT volume. Segmented landmarks included the internal limiting membrane, posterior surface of the RNFL, posterior surface of Bruch\'s membrane/retinal pigment epithelium complex, BMO, neural canal wall, anterior lamina cribrosa surface, anterior scleral surface, and the ASCO (segmented on each side of the canal by visually projecting the plane of the peripapillary anterior scleral surface through the neural canal wall and marking their intersection).[@i1552-5783-60-2-795-b01] All manual segmentations were performed by observers at the Optic Nerve Head Research Laboratory, Devers Eye Institute (Portland, OR, USA).

PCT, Percent PCT (%PCT), and ASCO Area {#s2d}
--------------------------------------

Quantification of all parameters was performed within custom software (Matlab version 7.3.0.267; The MathWorks, Natick, MA, USA). All left eye data were converted to right eye configuration. For each OCT 24 radial B-scan data set, a plane was fit to the 48 segmented ASCO points ([Fig. 1](#i1552-5783-60-2-795-f01){ref-type="fig"}), satisfying a least mean square error restraint as previously described for both BMO and ASCO in a series of publications.[@i1552-5783-60-2-795-b01],[@i1552-5783-60-2-795-b19] The Bruch\'s membrane, anterior scleral surface, and ASCO points were interpolated using B-splines. The interpolated Bruch\'s membrane points and anterior scleral surface points were then resampled at equal distances from BMO and the ASCO, respectively, allowing the consistent sampling of each surface between the original segmentation points.

PCT was measured at six distances from the ASCO (hereafter referred to as ASCO measurement distances: 100 μm \[PCT-100\], 300 μm \[PCT-300\], 500 μm \[PCT-500\], 700 μm \[PCT-700\], 900 μm \[PCT-900\], and 1100 μm \[PCT-1100\]) measured within the ASCO reference plane and projected to the anterior scleral surface ([Fig. 2](#i1552-5783-60-2-795-f02){ref-type="fig"}). At each anterior scleral measurement point, PCT was defined by the minimum distance to the posterior surface of Bruch\'s membrane. However, when internally or externally oblique border tissues were present in a given study eye ([Fig. 3](#i1552-5783-60-2-795-f03){ref-type="fig"}), PCT measurements within the regions of internally and externally oblique border tissues (most often at the 100 μm and 300 μm measurement points) were not included in the normative values because the density of the border tissues themselves and the adjacent choroidal septa made the presence of active choroidal vasculature difficult to determine. Global and sectoral %PCT were calculated for each study eye, at each ASCO distance, as the PCT divided by the mean PCT of the study population at that location. ASCO area was calculated after projection of the ASCO points onto the ASCO reference plane, as previously reported.[@i1552-5783-60-2-795-b01]

Regionalization {#s2e}
---------------

Twelve 30° sectors (centered on each clock hour) were established relative to the FoBMO axis as previously described ([Fig. 4](#i1552-5783-60-2-795-f04){ref-type="fig"}).[@i1552-5783-60-2-795-b01],[@i1552-5783-60-2-795-b26]

![FoBMO 30° ONH sectors for a representative study eye (FDA056). The fovea (yellow dot) and four BMO points were anatomically identified using real-time OCT imaging at the time of image acquisition by the technician. The delineated BMO points from the 24 acquired OCT B-scans are projected onto the IR image along with the geometric center of BMO (BMO centroid - red dot with yellow border) so as to establish the foveal to BMO (FoBMO) axis. Twelve 30° (clock-hour) sectors were then established relative to the FoBMO axis. Note that the use of the FoBMO axis for orientation rather than the acquired image frame vertical and horizontal axes (blue dotted lines) means that the 12 FoBMO sectors were applied in an anatomically consistent fashion to each study eye.[@i1552-5783-60-2-795-b24],[@i1552-5783-60-2-795-b26],[@i1552-5783-60-2-795-b58] S, superior; SN, superior nasal; NS, nasal superior; N, nasal; NI, nasal inferior; IN, inferior nasal; I, inferior; IT, inferior temporal; TI, temporal inferior; T, temporal; TS, temporal superior; ST, superior temporal.](i1552-5783-60-2-795-f04){#i1552-5783-60-2-795-f04}

Interobserver Reproducibility {#s2f}
-----------------------------

Interobserver segmentation reproducibility was assessed at each PCT measurement distance by having four observers each segment the same eight OCT data sets. For each OCT data set, global and sectoral values for PCT at all six ASCO measurement distances were computed for each observer. Interobserver reproducibility for ASCO area has been previously reported.[@i1552-5783-60-2-795-b01]

Statistical Analysis {#s2g}
--------------------

All statistical analyses were performed in R version 3.1.3 (The R Foundation for Statistical Computing, Vienna, Austria). Intraclass correlation coefficients (ICC) between observers for each global and sectoral parameter (i.e., one global value and 12 sectoral value per distance per participant per observer) were calculated using a 2-way analysis of variance (ANOVA).[@i1552-5783-60-2-795-b29],[@i1552-5783-60-2-795-b30]

The effects of measurement distance from the ASCO, age, axial length, sex, ethnicity, and IOP on overall global PCT were assessed within an ANOVA by general linear model using generalized estimation equation (GEEGLM). Univariate regression models were formed to relate global PCT at each measurement location with age, ASCO area, axial length, and IOP. The significance and magnitude of the effects of age, axial length, ASCO area, IOP, sex, and ethnicity on global PCT at each measurement location were assessed by calculating the proportion of the total variance (*R*^2^) within an ANOVA with a linear regression model. Coefficients for each of these effects on global choroidal thickness at each measurement location were also assessed within a multivariate linear regression model.

For sectoral PCT, an initial overall ANOVA was performed with a generalized estimation equation model to assess the significance of age, ASCO area, axial length, sex, ethnicity, sector, ASCO distance, sector versus age, measurement distance versus age, measurement distance versus sector, and distance versus sector versus age. A follow-up ANOVA was then performed to assess the significance of age, ASCO area, axial length, sex, ethnicity, sector, and sector-versus-age effects on sectoral choroidal thickness at each measurement location. These two ANOVA analyses were also performed on sectoral %PCT data. Finally, within sectoral PCT and sectoral %PCT data, comparisons between the sectors with the three largest thickness values and the sectors with the three smallest thickness values or between the sectors with the three fastest and three slowest age-related change rates were performed with a generalized estimation equation model. Statistical significance was assumed when *P* ≤ 0.05.

Results {#s3}
=======

Demographic and ocular data for all 362 participants are summarized in [Table 1](#i1552-5783-60-2-795-t01){ref-type="table"}. Because there were very few Asian and Native American descent participants, ethnicity was reduced to four groups (European descent, Hispanic ethnicity, African descent, and combined Asian and Native American descent) for subsequent analyses. Five participants (1.4%) were excluded from the analysis of PCT because of poor visualization of the anterior scleral surface at all measurement distances. A total of 48 participants (13.3%) and 5 participants (1.4%) were excluded from the analysis at the 100 and 300 μm measurement distances, respectively, as a result of externally oblique border tissues that extended beyond these measurement points ([Fig. 3](#i1552-5783-60-2-795-f03){ref-type="fig"}). A total of 12 participants (3.3%) were excluded from the analysis at the 1100 μm measurement distance as a result of the B-scans not extending to this distance. Age, axial length, ASCO area, and IOP were not significantly different by ethnicity (ANOVA, *P* values ≥ 0.05). The proportion of females and left eyes were not significantly different (χ^2^ test, *P* = 0.41). Central cornea thickness and spherical equivalent were statistically different among the ethnic groups (ANOVA, *P* ≤ 0.05; [Table 1](#i1552-5783-60-2-795-t01){ref-type="table"}).

###### 

Demographic and Ocular Characteristics of the Study Participants

  Characteristics                **All Subjects, *n* = 362**   **European Hispanic Descent, *n* = 246**   **Hispanic Ethnicity, *n* = 47**   **African Descent, *n* = 47**   **Asian and Native American Descent, *n* = 22**\*   **ANOVA or Chi-Square Test,** ***P*** **Value**†
  ------------------------------ ----------------------------- ------------------------------------------ ---------------------------------- ------------------------------- --------------------------------------------------- --------------------------------------------------
  Female, *n* (%)                202 (56)                      137 (56)                                   30 (64)                            22 (47)                         13 (59)                                             0.41‡
  Left eye, *n* (%)              181 (50)                      123 (50)                                   24 (51)                            25 (53)                         9 (41)                                              0.83‡
  Age, y (SD)                    50.62 (17.53)                 52.17 (18.27)                              45.28 (14.07)                      49.40 (14.76)                   47.27 (19.25)                                       0.06
  Axial length, mm (SD)          23.74 (0.95)                  23.67 (0.91)                               23.87 (1.02)                       23.80 (1.03)                    24.07 (1.11)                                        0.18
  ASCO area, mm^2^ (SD)          2.23 (0.43)                   2.21 (0.44)                                2.31 (0.45)                        2.21 (0.41)                     2.30 (0.38)                                         0.40
  IOP, mm Hg (SD)                14.53 (2.70)                  14.56 (2.71)                               14.27 (2.67)                       14.91 (2.73)                    13.95 (2.54)                                        0.49
  CCT, μm (SD)                   555.31 (32.60)                555.49 (34.52)                             555.71 (25.99)                     545.60 (29.09)                  573.21 (22.01)                                      0.01
  Spherical equivalent, D (SD)   −0.47 (1.82)                  −0.29 (1.72)                               −0.43 (1.90)                       −0.78 (1.77)                    −1.93 (2.14)                                        \<0.0001

CCT, central corneal thickness; D, diopters.

A total of 19 (5.2%) Asians and 3 (0.8%) Native Americans.

ANOVA or chi-square test to check if ethnicity is significant different for a demographic parameter.

Chi-square test.

Interobserver Reproducibility {#s3a}
-----------------------------

Between-observer ICC values for all parameters assessed globally ranged from 0.83 to 0.96 and sectorally were ≥ 0.8 for all sectors at measurement distances ≥ 300 μm, except for the nasal--superior sector at the 300 μm measurement point, where the ICC was 0.78. Sectoral ICCs at the 100 μm measurement point were lower, ranging from 0.62 to 0.86, except for the temporal sector (ICC 0.57).

Global PCT {#s3b}
----------

Global PCT was significantly influenced by age, ASCO area, axial length, ethnicity, measurement distance from the ASCO, sex, and the interactions between measurement distance versus age by ANOVA (*P* ≤ 0.05, GEEGLM).

Global PCT by Distance From ASCO {#s3c}
--------------------------------

Population means, medians, confidence intervals, and ranges for global PCT at each measurement distance are reported in [Table 2](#i1552-5783-60-2-795-t02){ref-type="table"}. Mean PCT was 108.81 μm at the PCT-100 measurement point and increased to 172.47 μm at the PCT-1100 measurement point. In the univariate regression models, age was negatively associated with PCT at all distances (*P* \< 0.0001; *R*^2^ values for each model ranging from 0.13--0.16; [Fig. 5](#i1552-5783-60-2-795-f05){ref-type="fig"}). The effect of age on PCT became more pronounced with increasing distance (−0.59 μm/year at PCT-100, progressively increasing to −1.43 μm/y at PCT-1100; [Fig. 5](#i1552-5783-60-2-795-f05){ref-type="fig"}). Axial length was weakly negatively associated with PCT at all distances (*P* \< 0.01; *R*^2^ values for each model ranging from 0.02--0.06; [Supplementary Fig. S1](#iovs-60-02-03_s02){ref-type="supplementary-material"}).

###### 

Global Mean PCT at Each Measurement Distance From the ASCO

  **Measurement Location\***   **Number of Eyes**†   **Mean**   **SD**   **Minimum**   **5% Percentile**   **Median**   **95% Percentile**   **Maximum**
  ---------------------------- --------------------- ---------- -------- ------------- ------------------- ------------ -------------------- -------------
  PCT-100                      309                   108.81     26.25    44.41         65.38               107.4        150.72               193.11
  PCT-300                      352                   129.30     37.46    37.6          66.27               128.75       192.05               242.60
  PCT-500                      357                   144.12     46.71    34.86         68.18               143.2        225.1                267.29
  PCT-700                      357                   156.45     53.88    36.41         71.22               154.4        252.64               295.84
  PCT-900                      357                   166.08     58.97    38.81         75.86               164.3        270.06               322.81
  PCT-1100                     345                   172.47     62.41    40.32         75.31               169.6        281.98               340.71

Measured relative to the ASCO.

Number of eyes with data at each measurement point (see the Results and Discussion).

![Scatterplot and univariate linear regression of PCT and age at each measurement point. Panels depict data at the 100, 300, and 500 μm measurement distances above and the 700, 900, and 1100 μm distances below. The slope of the regression line achieved significance at the P \< 0.0001 level at all distances from the ASCO. Solid blue lines indicate fitted linear regression lines; dotted blue curves indicate the 95% CI of the regression lines; gray circles with black border indicate individual eye values.](i1552-5783-60-2-795-f05){#i1552-5783-60-2-795-f05}

In multivariable analysis, increased age and axial length were negatively associated with PCT at all measurement distances ([Table 3](#i1552-5783-60-2-795-t03){ref-type="table"}, model *R*^2^ = 0.23--0.34). Increased ASCO area was also negatively associated with PCT for all distances ≥300 μm from the ASCO. PCT was thicker in eyes of African descent and Hispanic ethnicity at all measurement distances than European descent eyes (PCT-100: African 118.27 ± 20.91 μm, Hispanic 118.74 ± 23.13 μm, European 105.76 ± 26.65 μm; PCT-1100: African 208.39 ± 56.35 μm, Hispanic 200.62 ± 61.45 μm, European 162.58 ± 60.53 μm; *P* ≤ 0.01; [Fig. 6](#i1552-5783-60-2-795-f06){ref-type="fig"}). Differences between the African descent and Hispanic ethnicity groups did not achieve statistical significance at any distances (*P* = 0.173 to 0.887). The effectors that contributed most to explaining the variability of global PCT at each measurement distance were age (ranging from 13%--16%), axial length (ranging from 4%--10%), ethnicity (ranging from 2%--6%), ASCO area (ranging from 1%--2%), and sex (1%), respectively.

###### 

Multivariable Regression Coefficients for Demographic, Ocular, Sex, and Ethnicity Effects on PCT at Each Measurement Distance From the ASCO

  Parameter                                                  **PCT-100**   **PCT-300**   **PCT-500**   **PCT-700**   **PCT-900**   **PCT-1100**                                                          
  ---------------------------------------------------------- ------------- ------------- ------------- ------------- ------------- -------------- ------------ ------- ------------ ------- ------------ -------
  Intercept                                                  **295.14**    36.69         **472.55**    45.98         **612.77**    55.21          **711.54**   62.91   **783.92**   68.52   **818.43**   72.91
  Age                                                        **−0.62**     0.08          **−0.87**     0.10          **−1.14**     0.12           **−1.35**    0.14    **−1.51**    0.15    **−1.63**    0.16
  Axial length                                               **−6.02**     1.50          **−11.7**     1.83          **−15.93**    2.19           **−18.93**   2.49    **−21.13**   2.71    **−21.64**   2.90
  ASCO area                                                  −6.10         3.19          **−11.4**     3.96          **−15.27**    4.80           **−16.95**   5.47    **−17.6**    5.96    **−22.43**   6.83
  IOP                                                        −0.21         0.48          −0.33         0.62          −0.73         0.75           −0.92        0.85    −1.04        0.93    −1.04        1.00
  Sex (male vs. female)\*                                    4.83          2.72          6.16          3.45          **8.86**      4.15           **11.07**    4.73    **12.4**     5.15    **12.54**    5.53
  Ethnicity and race                                                                                                                                                                                     
   Hispanic ethnicity‡ vs. European descent†                 **10.65**     4.06          **19.35**     5.19          **25.30**     6.22           **30.04**    7.09    **32.67**    7.72    **34.75**    8.42
   African descent‡ vs. European descent†                    **9.90**      4.02          **27.64**     5.13          **36.33**     6.22           **41.57**    7.09    **43.15**    7.72    **43.79**    8.17
   Asian and Native American descent vs. European descent†   **−**4.56     6.21          **−**3.59     7.22          **−**4.42     8.57           **−**6.81    9.77    **−**9.27    10.64   **−**9.95    11.25

Bold indicates *P* ≤ 0.05.

Parameter in the male participants was compared to the same parameter in the reference female participants.

Parameters in African descent, Hispanic ethnicity, and Asian and Native American descent participants were compared with the same parameters in reference European descent participants separately.

African descent and Hispanic ethnicity participants were not significantly different overall or at any measurement distance.

![PCT by ethnicity and distance from the ASCO. The mean (± standard deviation) PCT for the four ethnicity groups are plotted for the six measurement distances from the ASCO. PCT was compared between European, Hispanic, and African descent ethnicities. PCT was thicker in the African descent and Hispanic ethnicity groups when compared with the European descent group, respectively, at all six distances from the ASCO ([Table 3](#i1552-5783-60-2-795-t03){ref-type="table"}). P values by general linear regression by general estimation equation model are depicted for each comparison in red or blue as follows: \#\#\#\#P \< 0.0001; \#\#\#P \< 0.001; \#\#P \< 0.01; \#P \< 0.05). The differences between the African descent and Hispanic ethnicity groups did not achieve significance.](i1552-5783-60-2-795-f06){#i1552-5783-60-2-795-f06}

Sectoral PCT {#s3d}
------------

PCT was thinnest within the inferior--nasal, inferior, inferior--temporal, and temporal sectors at all measurement distances ([Fig. 7](#i1552-5783-60-2-795-f07){ref-type="fig"}, upper row). The sectors with the thinnest PCT were significantly different from the sectors with the thickest PCT at all measurement distances ([Fig. 7](#i1552-5783-60-2-795-f07){ref-type="fig"}, upper row; *P* ≤ 0.05, general linear regression by GEEGLM).

![FoBMO sectoral mean PCT (upper row), age-related PCT change (middle row), and age-related percent PCT change (%PCT, lower row) at six proximal (PCT-100 μm) to distal (PCT-1100 μm) locations from the ASCO. Data are presented in right eye orientation (upper left) by 30° (clock-hour) sectors that are oriented relative to the FoBMO axis. The mean PCT within each sector at six measurement locations (extending from 100 μm from the ASCO (left most column) to 1100 μm from the ASCO (right most column) are shown (upper row). The mean PCT of the top three thickest sectors at each measurement distance are bold black. The mean PCT of the top three thinnest sectors are bold blue. The thinnest sectors are significantly thinner than the thickest sectors when they are accompanied by a number sign symbol (see below). The rate of PCT change with age in each sector (μm/y), after adjusting for axial length, ASCO area, IOP, ethnicity, and sex (middle row). The sectors with the top three slowest rates of change are bold black. The sectors with the top three fastest rates of change are bold blue. The rates of change of the fastest sectors are significantly faster than the slowest sectors when they are accompanied by a number sign symbol (legend below). The rate of %PCT change with age in each sector after adjusting for the same covariates (lower row). The sectors with the three lowest rates of %PCT change are bold black. The sectors with the three fastest rates of %PCT change are shown in bold blue. The fastest sectors are significantly faster than the slowest sectors when accompanied by a number sign symbol. Significant differences, by a general estimation equation model are depicted by \#\#\#P \< 0.001; \#\#P \< 0.01; and \#P \< 0.05, respectively.](i1552-5783-60-2-795-f07){#i1552-5783-60-2-795-f07}

The effect of sector on PCT remained significant after adjusting for all other effectors at each measurement distance (ANOVA; [Supplementary Table S1](#iovs-60-02-03_s01){ref-type="supplementary-material"}). Sectoral PCT was significantly influenced by age, ASCO area, axial length, ethnicity, sex, sector, measurement distance from the ASCO, and the interactions between sector versus age, measurement distance versus age, measurement distance versus sector, and measurement distance versus sector versus age, by ANOVA (by GEEGLM, *P* ≤ 0.05). In a separate ANOVA ([Supplementary Table S2](#iovs-60-02-03_s01){ref-type="supplementary-material"}), the effect of age and the effect of the sector-versus-age interaction on the %PCT were also significant at all measurement distances.

The thinnest sectors (upper row of [Fig. 7](#i1552-5783-60-2-795-f07){ref-type="fig"}) also demonstrated the most rapid thinning with age (middle and lower panels, [Fig. 7](#i1552-5783-60-2-795-f07){ref-type="fig"}). At all six measurement distances, the effects of age on PCT and %PCT in the sectors with the fastest rate of age-related thinning were significantly greater (*P* ≤ 0.05, general linear regression by GEEGLM model) than the effects of age in the sectors with the slowest rates of age-related thinning ([Fig. 7](#i1552-5783-60-2-795-f07){ref-type="fig"}, middle and lower rows). Age-related PCT reduction was from 15.6% to 20.7% greater in the faster sectors when compared with the slower sectors at six measurement distances.

Although the sectoral distribution of PCT was similar at all measurement distances (thinnest inferiorly and inferior temporally; [Fig. 7](#i1552-5783-60-2-795-f07){ref-type="fig"}, upper row), sectoral thickness variation increased substantially as the measurement distance from the ASCO increased. Sectoral PCT ranged from 101 to 115 μm at the PCT-100 μm measurement location and ranged from 143 to 189 μm at the PCT-1100 μm measurement location. Age-affected sectoral PCT ([Fig. 7](#i1552-5783-60-2-795-f07){ref-type="fig"}, middle row) and %PCT ([Fig. 7](#i1552-5783-60-2-795-f07){ref-type="fig"}, lower row) also increased in magnitude and variation as the distance from ASCO increased. Sectoral age effects on %PCT ranged from −0.52 to −0.69 %/y at the PCT-100 μm measurement location and from −0.86 to −1.18 %/y at the PCT-1100 μm measurement location.

Discussion {#s4}
==========

This study characterizes PCT in a large healthy population and introduces both the use of the ASCO as the neural canal reference opening for its measurement and the use of the FoBMO axis as the common horizontal axis for its regionalization. Our findings suggest that OCT PCT is thinnest in the inferior temporal sectors and thinnest closest to the ASCO. Thinner PCT was associated with age, axial length, European descent, and weakly associated with larger ASCO area and female sex, respectively. Among these effects, age had the strongest influence, and its effect was greatest within the inferior temporal sectors. Although the clinical significance of the effects we describe remains to be determined, our approach to quantifying PCT as well as the findings we report provide a foundation for incorporating PCT into existing OCT strategies to diagnose and follow optic neuropathies. Our approach has also yielded sectoral data that gives an indication of the changes in PCT to be expected with normal aging against which disease-related changes can be gauged.[@i1552-5783-60-2-795-b01],[@i1552-5783-60-2-795-b24],[@i1552-5783-60-2-795-b31]

In general, the PCT values we report are similar to the existing literature, although among all previous studies there are differences in scan pattern and location, imaging device, age distribution, ethnicity, and reference point (most being relative to BMO or derived from standard RNFL circle scans). Rhodes et al.[@i1552-5783-60-2-795-b32] reported an average PCT ranging from 63.9 μm (0--250 μm from BMO) to 164.8 μm (1000--1500 μm from BMO) in 166 normal eyes of European and African descent participants using a Spectralis OCT 24 radial B-scan pattern. Lee et al.[@i1552-5783-60-2-795-b17] reported an average PCT to be 135.6 μm in 48 normal Korean eyes 500 μm from the border tissues of Elschnig using a Topcon swept source OCT and a 12 B-scan pattern. However, Park et al.[@i1552-5783-60-2-795-b15] reported an average PCT to be 226.35 μm in 48 healthy Korean participants within the region of the choroid 300 to 1800 μm from BMO using a Spectralis OCT and a 6 B-scan ONH radial pattern.

The thickness in the Park et al.[@i1552-5783-60-2-795-b15] study was larger than our data obtained 1100 μm from the ASCO, larger than the average thicknesses of most other studies and may be a reflection of the longer sampling distance from BMO in that study (because choroidal thickness increases progressively as the distance from BMO or ASCO increases). Although it may also be the case that the choroid is thicker in Korean eyes, Chung et al.[@i1552-5783-60-2-795-b33] measured PCT using Spectralis circle scans in 87 healthy Korean eyes and reported an average thickness of 157.3 μm, which is within the confidence intervals of our measurements at 900 and 1000 μm (roughly the position of a standard circle scan within our data). Several other studies have reported global PCT within standard 12° (or 3.4 mm diameter) circle scans in a wide variety of healthy participants that varies from 130 μm to 167 μm,[@i1552-5783-60-2-795-b34][@i1552-5783-60-2-795-b35][@i1552-5783-60-2-795-b36][@i1552-5783-60-2-795-b37][@i1552-5783-60-2-795-b38][@i1552-5783-60-2-795-b39][@i1552-5783-60-2-795-b40][@i1552-5783-60-2-795-b41]--[@i1552-5783-60-2-795-b42] which are again within the confidence intervals of our measurements at the PCT-900 μm and PCT-1000 μm measurement points.

The peripapillary choroid was thinnest within the inferior sectors of our study eyes, which agrees with a series of previous reports.[@i1552-5783-60-2-795-b15],[@i1552-5783-60-2-795-b17],[@i1552-5783-60-2-795-b32],[@i1552-5783-60-2-795-b34],[@i1552-5783-60-2-795-b41],[@i1552-5783-60-2-795-b43],[@i1552-5783-60-2-795-b44] However, our finding that age-related peripapillary choroidal thinning was greatest within the inferior temporal sectors has not previously been reported. This finding complements a growing literature that suggests that age-related changes in the neuroretinal rim[@i1552-5783-60-2-795-b24],[@i1552-5783-60-2-795-b45] and RNFL[@i1552-5783-60-2-795-b24] are greatest within the inferior temporal region of the ONH, where glaucomatous damage is thought to be most frequent.[@i1552-5783-60-2-795-b46] In contrast, a recent study in a healthy Japanese population found age effects on the rim and RNFL tissues to be greatest in the superior nasal rather than the inferior temporal sectors.[@i1552-5783-60-2-795-b31] Because our approach also quantifies ONH rim tissue and RNFL measurements, this will afford longitudinal studies to determine the relative timing and sectoral correlation of choroidal ONH rim tissue and RNFL thinning in aging and glaucoma to be performed.

Many previous studies have reported that increasing age is associated with a thinner peripapillary choroid.[@i1552-5783-60-2-795-b16],[@i1552-5783-60-2-795-b17],[@i1552-5783-60-2-795-b32],[@i1552-5783-60-2-795-b34],[@i1552-5783-60-2-795-b41] In our study, age played the largest role in explaining the variance in PCT (from 13%--16% depending on the distance from the ASCO). After adjusting for other significant effectors, age-related decline in global peripapillary choroid thickness ranged from −0.62 μm per year 100 μm from the ASCO to −1.63 μm per year 1100 μm from the ASCO, which is similar to the rates reported in other studies.[@i1552-5783-60-2-795-b16],[@i1552-5783-60-2-795-b17],[@i1552-5783-60-2-795-b32],[@i1552-5783-60-2-795-b34],[@i1552-5783-60-2-795-b41]

Axial length demonstrated the second most important influence on PCT in our study. Several studies have reported that longer axial length is associated with thinner peripapillary choroid in normal eyes.[@i1552-5783-60-2-795-b32],[@i1552-5783-60-2-795-b38],[@i1552-5783-60-2-795-b40] However, given our inclusion criteria for refractive error and axial length, we excluded highly myopic eyes. The relationship between PCT and axial length may have been stronger with the inclusion of highly myopic eyes. Other significant influences in our study included ethnicity, ASCO area, and sex, although male eyes demonstrated only slightly thicker PCT, which achieved significance at the most distal measurement locations. We found PCT to be thicker in African descent and Hispanic ethnicity participants at all distances from the ASCO. Rhodes et al.[@i1552-5783-60-2-795-b32] previously reported thicker choroidal thickness in African descent eyes when compared with European descent eyes at all distances from the BMO.

The limitations of this study include the relatively small number of non-European descent participants, which will be addressed by completion of PCT measurements in 258 healthy Japanese participants,[@i1552-5783-60-2-795-b31] completion of ongoing African descent and Hispanic ethnicity group expansions to 250 participants each, and the eventual completion of a planned study of 250 healthy participants from mainland China. Because of the heterogeneous nature of Hispanic ethnicity, the fact that PCT differences between the African descent and Hispanic ethnicity groups did not achieve significance may have been the result of the presence of a substantial amount of African heritage in the participants who self-identified as Hispanic in this study. Additional studies in a variety of African descent and Hispanic ethnicity participants are required.

In this article (and the article that precedes it[@i1552-5783-60-2-795-b01]), we identified the ASCO by projecting the immediate peripapillary scleral surface through the border tissues of Elschnig to the neural canal wall boundary ([Fig. 2](#i1552-5783-60-2-795-f02){ref-type="fig"}). Unlike BMO, which is an anatomically identifiable structure in most nonmyopic[@i1552-5783-60-2-795-b18] eyes by histology and by OCT,[@i1552-5783-60-2-795-b19],[@i1552-5783-60-2-795-b47],[@i1552-5783-60-2-795-b48] the ASCO is not an anatomically identifiable structure in either modality. Instead the ASCO must be estimated, rather than anatomically identified, as outlined previously. However, interoperator reproducibility of global ASCO area and PCT relative to ASCO was excellent in this study. Altough the reproducibility of choroidal thickness was generally good sectorally, it was diminished for the 100 μm measurement point in those sectors where the peripapillary choroid was thinnest. The importance of including the ASCO in human ONH phenotyping has been previously discussed.[@i1552-5783-60-2-795-b01] Studies that seek predictive relationships between cross-sectional PCT, longitudinal PCT change, peripapillary atrophy, and glaucomatous or myopic rim and RNFL loss are indicated. In these studies, the effect of using ASCO versus BMO as the reference opening for the measurement should also be assessed.

Finally, to ensure that our most important findings were preserved, we recalculated PCT measurements at the same measurement distances from BMO ([Supplementary Fig. S2](#iovs-60-02-03_s02){ref-type="supplementary-material"}) instead of from the ASCO. Comparing the BMO-based PCT values in [Supplementary Table S3](#iovs-60-02-03_s01){ref-type="supplementary-material"} to the ASCO-based PCT values in [Table 2](#i1552-5783-60-2-795-t02){ref-type="table"}, the progressive increase in PCT from the scleral canal to the macula is still present. However, there are less BMO PCT-100 measurement values when compared with the number of ASCO PCT-100 values, and the BMO PCT values are modestly smaller than the ASCO PCT values at all measurement points. Comparing sectoral age effects using ASCO as the reference ([Fig. 7](#i1552-5783-60-2-795-f07){ref-type="fig"}) to sectoral age effects using BMO ([Supplementary Fig. S3](#iovs-60-02-03_s02){ref-type="supplementary-material"}) reveals identical trends in both analyses, although the higher inferior temporal sectoral age effects achieve significance at the ASCO PCT-100 measurement point but do not achieve statistical significance at the BMO PCT-100 measurement point. We believe that these differences are a direct result of internally oblique border tissues being more common and extensive than externally oblique border tissues in human eyes.[@i1552-5783-60-2-795-b20] In the setting of internally oblique border tissues, the BMO PCT measurement points, at every measurement distance, fall closer to the scleral canal than the ASCO PCT measurement points of equal distance. As a consequence, more BMO PCT 100 measurement points fall within internally oblique border tissues (and as a result are excluded), and the BMO PCT measurements at all distances from the BMO are closer to the ONH, and thus smaller than the ASCO PCT measurements of equal distance.

In summary, the OCT PCT was thinnest within the inferior temporal sectors, and thinner PCT was most strongly associated with older age, axial length, and European descent and weakly associated with larger ASCO area and female sex. Among these effects, age had the strongest influence, and its effect was greatest within the inferior temporal sectors. Although the clinical significance of our findings remain to be determined, our techniques provide a foundation for incorporating PCT into strategies for detecting and staging the optic neuropathies of human aging,[@i1552-5783-60-2-795-b01],[@i1552-5783-60-2-795-b10],[@i1552-5783-60-2-795-b24],[@i1552-5783-60-2-795-b31],[@i1552-5783-60-2-795-b45],[@i1552-5783-60-2-795-b49] pathologic myopia,[@i1552-5783-60-2-795-b04][@i1552-5783-60-2-795-b05][@i1552-5783-60-2-795-b06][@i1552-5783-60-2-795-b07]--[@i1552-5783-60-2-795-b08] and glaucoma.[@i1552-5783-60-2-795-b50][@i1552-5783-60-2-795-b51][@i1552-5783-60-2-795-b52][@i1552-5783-60-2-795-b53]--[@i1552-5783-60-2-795-b54]

Supplementary Material
======================

###### 

Click here for additional data file.

###### 

Click here for additional data file.

Partial material was previously presented at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Baltimore, Maryland, United States, May 2017.
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